Legends Awaken in Darkness Rises Third Anniversary Update
Darkness Rises, Nexon America’s third-person action mobile role-playing game (RPG), is celebrating its third anniversary with a host of new content, special anniversary events, and rewards including a free gift to all who login starting today through August 22, 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210720005450/en/
Legends Awaken in Darkness Rises Third Anniversary Update (Graphic: Business Wire)
The Legends Awaken update adds exciting new content that not only commemorates the third anniversary milestone, but advances game lore with the new skill Character Awakening, new Demonic Raid, the new Royal Kitty Pet, and an assortment of anniversary events allowing players to join in on the celebration.
- New skills - Character Awakening: Allows existing characters to surpass their current abilities by unlocking powerful new skills and Awakening traits. Character Awakening Skills improve the overall power of character abilities, increasing the power to the maximum skill and enhancement levels of the character.
- New Demonic Raid: In addition to learning new skills, players can take on the brand new real-time co-operative raid against the latest high level boss Bakura with up to two other players and bag the all-new high level Rank L equipment, craft even more top level gear with materials you win, and earn bonus rewards for playing with guild members.
- Events/Equipment: To help players bolster their last line of defense against the Demonic commanders, take part in the upcoming events and new raid to ensure you and your team have what it takes to protect the Mortal Plane from Bakura’s invasion while he is still at only 30% strength. Go even further by earning exclusive Wings from completing the Demonic Raid.
In addition to the Legends Awaken game content, the update also adds a series of timed events and rewards for players to join in on the celebration with the following anniversary events:
- Free Gift - From July 20 through August 22, all players who log into the game will receive a free gift just for logging in during the anniversary event; the gift includes two Level 60 Rank S++ Weapons
- 3rd Anniversary Login Event - From now through August 16, players who log into the game for consecutive days will receive a variety of Gold, Gems, Pet Summon Tickets, Gear Summon Tickets, Rank S Refining Stones, Rank S Jewels, and Rank S Runes. Players who log in for the full seven days will receive the previous rewards plus Rank S++ Gear
- Lucky Spin - From July 20 through August 17, a special roulette event will be held at Iron Guard Square, where players can earn four types of third anniversary coins once per day, and coins can be sold in exchange for gold
- Costume Collection - From July 20 through August 17, players who collect all parts of any specific costume that are in Costume Treasure Chest #9, will receive a buff for that character that will last for four weeks.
- Mission Event - From July 20 through August 17, players can complete certain missions during the allocated event time period and earn points which can be used to redeem a wealth of new items including Rank L Awakening Stones, Rank L skill change tickets, Pet Eggs, high level crafting materials and more.
The update also features brand new Military Band costumes, new Awakening Link skills and more than 19 selectable passive Awakening traits to choose from.
About Darkness Riseshttps://dr.nexon.com/
Launched in 2018, Darkness Rises is a revolutionary, next-gen action RPG from Nexon that combines breathtaking graphics, state-of-the-art immersive gameplay and harrowing boss battles right in the palm of your hands. Featuring unique classes and beautifully rendered battles on iOS and Android, Darkness Rises has amassed over 23 million players, 35 million curated characters and 2.4 million completed quests since launch.
About Nexon America Inc.https://www.nexon.com/
Founded in 2005, Nexon America Inc. delivers outstanding free-to-play online game expertise and live game support, taking the strengths of NEXON Co., Ltd. (“Nexon”) and applying them for uniquely western audiences. Nexon America has consistently sustained iconic franchises such as MapleStory and Mabinogi for more than a decade, which have gone on to break records and captivate players. With new projects on the horizon, Nexon America maintains the pioneering and innovative spirit of its parent company, employing its player-first approach, while designing the best possible gameplay experiences for the western market.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Media Contact Information
About Business Wire
Subscribe to releases from Business Wire
Latest releases from Business Wire
Blackstone and Hudson Pacific Properties Announce Plans for New World-Class Film and TV Studios in the UK2.8.2021 09:00:00 CEST | Press release
Blackstone (NYSE: BX) and Hudson Pacific Properties (NYSE: HPP) plan to create a major new centre for film, TV and digital production in Broxbourne, Hertfordshire. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210802005278/en/ Artist Impression No. 1 (Photo: Business Wire) Funds managed by Blackstone Real Estate Partners and Hudson Pacific Properties acquired a 91-acre site, 17 miles north of central London, through a joint venture for £120 million. The acquisition, with an expected total investment of over £700 million, will be the partners’ first expansion of their Sunset Studios platform outside of the US. The proposed development, which is subject to planning permission, would transform the site into one of the largest world-class film and television studio campuses. The project is expected to create over 4,500 permanent jobs for Broxbourne and the surrounding community and contribute more than £300 million annually int
AMICOGEN Inc. and Lysando AG Bring Partnership to the Next Level With Ownership Participations in Each Other’s Companies2.8.2021 08:00:00 CEST | Press release
South Korean KOSDAQ listed AMICOGEN Inc. will become the latest shareholder in Lysando AG. The transaction includes an acquisition of shares, a cash contribution to Lysando and a share package to Lysando into AMICOGEN. The deal means an 8% participation of AMICOGEN into Lysando and 2.69% in shares for Lysando into AMICOGEN. The transactions were negotiated with a 300 Mio. Euro evaluation of Lysando. Other shareholders of Lysando continue to be majority owner and Chairman of the Board Markus Graf Matuschka von Greiffenclau, Bangkok based SCG, and Lysando’s employees. The companies have already a productive partnership in place, based on Lysando´s leading platform Artilysin®. It is a globally patented, sustainable and highly effective technology, fighting resistance of microbes, as an alternative to antibiotics and other antimicrobial treatments. „I am very happy and proud to welcome AMICOGEN as a new shareholder of Lysando. AMICOGEN being such a strong and successfully operating CDMO, A
Leicester’s Hospitals Awards Deenova a Unit Dose Pharmacy Automation 15 Year Contract2.8.2021 08:00:00 CEST | Press release
Deenova reported today it signed its first ever contract in the United Kingdom, and established operations in Europe’s second largest GDP health care market, with the NHS being the eight largest employer in the world. Deenova was selected by University Hospitals of Leicester NHS Trust as the best solution amongst 8 of Deenova's competitors in United Kingdom and the United States of America. Claire Ellwood, chief pharmacist at University Hospitals of Leicester NHS Trust, said: “We’re proud to be working with Deenova to deploy the first unit dose closed loop medicines management system in the UK. Every year, we administer millions of medication doses so it’s vital our processes are as safe and efficient as possible. The partnership with Deenova will increase automation within our medication processes helping to reduce errors and wastage as well as freeing up staff time for other care and tasks. After a successful pilot, we are pleased to start planning the roll out across our three hospi
Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders2.8.2021 07:00:00 CEST | Press release
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210801005028/en/ Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) and Exicure Inc. (NASDAQ: XCUR) have signed an exclusive collaboration agreement to research, develop, and commercialize novel Spherical Nucleic Acids (SNAs) as potential investigational treatments for Huntington’s disease and Angelman syndrome. Oligonucleotides are synthetic structures of nucleic acids that can be used to modulate gene expression via a range of processes, including gene activation, inhibition, and splice-modulation. These molecules have demonstrated potential in many different therapeutic areas.1 Achieving efficient oligonucleotide delivery to target organs and tissues, including the brain, remains a major limitation to their use.1,2 Exicure’s SNAs provide distinct chemical and biochemical properties to oligonucleotides. I
Arqit Releases QuantumCloud™ to Deliver Stronger, Simpler Encryption2.8.2021 06:20:00 CEST | Press release
Arqit Limited (“Arqit”), a leader in quantum encryption technology announces the release of the first version of its service, QuantumCloud™ 1.0. This Platform‑as‑a‑Service software enables customers to secure the communications channels and data of any cloud, edge or end-point device. The service combines transformational and unique advances in both quantum and classical cryptography. The release of QuantumCloud™ 1.0 allows customers to secure devices globally by providing a strong device authentication capability, over which is layered the agreement of symmetric keys between authenticated and authorised devices. Importantly, since there are no asymmetric cryptographic primitives used within the trustless key agreement protocol, the keys can be regarded as safe against future attack using Shor’s algorithm running on a quantum computer. A range of other features will be added in future quarters, culminating in the launch of Arqit’s proprietary quantum satellites, which is targeted for 2
Arqit Registration Statement Related to Business Combination With Centricus Acquisition Corp. Declared Effective By SEC2.8.2021 06:04:00 CEST | Press release
Arqit Limited (“Arqit”), a leader in quantum encryption technology today announced the Registration Statement on Form F-4 in connection with the previously announced business combination (the “Business Combination”) with Centricus Acquisition Corp. (“Centricus”) (Nasdaq: CENHU, CENH, CENHUW), a publicly-listed special purpose acquisition company, has been declared effective by the Securities and Exchange Commission (the “SEC”). Upon closing, the ordinary shares and warrants of Arqit Quantum Inc., a company formed for purposes of completing the Business Combination, will be listed on NASDAQ under the new ticker symbols “ARQQ” and “ARQQW.” The boards of directors of Arqit and Centricus have unanimously approved the Business Combination, and Centricus has set 9:00 a.m. ET on August 31, 2021 as the time and date for an extraordinary general meeting of shareholders to approve the proposals associated with the Business Combination. The proxy statement/prospectus contains important informatio
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie2.8.2021 01:30:00 CEST | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30, 2021 (IST) to uphold the Irish Revenue Commissioners’ position related to the treatment of a break fee received by Shire plc (“Shire”) in October 2014 from AbbVie Inc. (“AbbVie”). Shire was acquired by Takeda in January 2019. Takeda intends to challenge this outcome through all available legal means including appealing the decision to the Irish courts. On November 28, 2018, Shire received a tax assessment from the Irish Revenue Commissioners for 398 million EUR. This assessment sought to tax a 1,635 million USD break fee Shire received from AbbVie in connection with the terminated offer to acquire Shire made by AbbVie in 2014. Takeda appealed this assessment, and in late 2020 a hearing took place before the Irish Tax Appeals Commission. While Takeda is continuing to assess the substance of the decision, the company will record a